Finance

Gracell looks to NASDAQ IPO to place it among CAR T leaders

Suzhou company shines in first day of trading after raising more than $200M

Suzhou-based Gracell Biotechnologies hopes its listing on the U.S. exchange will put it on the map as a global player in CAR T therapies.

Gracell has